Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The company raised $200 million after early findings hinted its therapy could be more potent than others like it, including ...

Solid Biosciences' SGT-003 gene therapy showed strong dystrophin expression, muscle health improvements, and no serious safety concerns in early trial data.

Solid said that the first patients to receive its Duchenne gene therapy all produced high levels of the target protein, an ...

Shares of Solid Biosciences (NASDAQ:SLDB) jumped ~88% in the premarket on Tuesday after the gene therapy developer reported ...

Day 90 biopsy data reported from first 3 participants dosed in Phase 1/2 INSPIRE DUCHENNE trial —— Average microdystrophin expression of 110% ...

Leah Messer is opening up about navigating her daughter Ali's muscular dystrophy as the 15-year-old takes a big step in her life: high school. In an interview with TooFab ahead of the new season ...

2025 could be a breakout year for the Duchenne muscular dystrophy space. Although several therapies have entered the market in recent years, there is still considerable unmet need for the 15,000 ...

According to NBA insider Marc Stein, there is "optimism" that Dallas Mavericks star Luka Dončić will return to the team from his calf injury before the NBA All-Star break. Dallas' final game ...

NEW YORK – Belief BioMed announced Wednesday that the US Food and Drug Administration has cleared its investigational new drug application enabling it to begin testing its gene therapy candidate for ...

Get Instant Summarized Text (Gist) Muscular strength and cardiorespiratory fitness are significantly linked to a lower risk of death in cancer patients. A pooled analysis of 42 studies involving ...

According to the researchers, “this ‘normalizing’ effect of once weekly prednisone was similar to higher doses used in the DMD [Duchenne muscular dystrophy] patients and may indicate these biomarkers ...